Product
Quadrivalent Influenza mRNA Vaccine MRT5410
1 clinical trial
1 indication
Indication
Influenza ImmunizationClinical trial
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adults Aged 18 Years and OlderStatus: Completed, Estimated PCD: 2024-03-28